Cognition in Parkinson's disease
Studies of accentuated drop in cognitive functioning of Parkinson's disease patients mostly use global intelligence measures that have a masking effect on differential drop in specific cognitive abilities. The goal of this study was to investigate the possible differential drop in different typ...
Gespeichert in:
| Veröffentlicht in: | Croatian medical journal 2004-08, Vol.45 (4), p.451-456 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 456 |
|---|---|
| container_issue | 4 |
| container_start_page | 451 |
| container_title | Croatian medical journal |
| container_volume | 45 |
| creator | Basić, Jasna Katić, Silvija Vranicć, Andrea Zarevski, Predrag Babić, Tomislav Mahović-Lakusić, Darija |
| description | Studies of accentuated drop in cognitive functioning of Parkinson's disease patients mostly use global intelligence measures that have a masking effect on differential drop in specific cognitive abilities. The goal of this study was to investigate the possible differential drop in different types of cognitive tasks. Applied tests tapped fluid and crystallized intelligence, memory, and metacognition.
A sample of 116 participants participated in the study. Half of the participants were diagnosed with Parkinson's disease (average duration of disease 6.5 years) and control group participants equaled them in age, sex, and education level. All participants were tested using Raven's Colored Progressive Matrices (CPM), Crichton Vocabulary Scale (CVS), memory subtests from Wechsler Adult Intelligence Scale (WAIS DS-F, WAIS DS-B), and Mini-mental Status Examination (MMSE). Participants, and in the case of clinical group their caregivers as well, were asked questions concerning their metamemory and metacognition.
Parkinson's disease patients scored lower than control group on all instruments used but the difference was significant only on CPM (F[1,114]=19.14, p=0.001) and MMSE (F[1,110]=4.04, p=0.047).
Patients with Parkisons' disease have greater cognitive damage in fluid intelligence than in crystallized intelligence. They seem to have relatively accurate metamemory and metacognition. |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_66786778</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66786778</sourcerecordid><originalsourceid>FETCH-LOGICAL-p207t-ad7e04bf07e8c6a97982b0a94645c2a4d4077d6089f06352bf5961254c4185193</originalsourceid><addsrcrecordid>eNo1j7tOxDAQRV2A2GXhF1AqqCKN7fGrRBEvaSUooI6cxEGGxA6ZpODvWYnd6jRHR_eesS1IJUunADfskugLQACivmAbriTnyO2WFVX-THGJORUxFW9-_o6JcrqjoosUPIUrdt77gcL1kTv28fjwXj2X-9enl-p-X04CzFL6zgTApgcTbKu9M86KBrxDjaoVHjsEYzoN1vWgpRJNr5zmQmF7mKG4kzt2-9-d5vyzBlrqMVIbhsGnkFeqtTZWG2MP4s1RXJsxdPU0x9HPv_Xpk_wDphNEUw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66786778</pqid></control><display><type>article</type><title>Cognition in Parkinson's disease</title><source>MEDLINE</source><source>Directory of Open Access Journals</source><source>EZB Electronic Journals Library</source><creator>Basić, Jasna ; Katić, Silvija ; Vranicć, Andrea ; Zarevski, Predrag ; Babić, Tomislav ; Mahović-Lakusić, Darija</creator><creatorcontrib>Basić, Jasna ; Katić, Silvija ; Vranicć, Andrea ; Zarevski, Predrag ; Babić, Tomislav ; Mahović-Lakusić, Darija</creatorcontrib><description>Studies of accentuated drop in cognitive functioning of Parkinson's disease patients mostly use global intelligence measures that have a masking effect on differential drop in specific cognitive abilities. The goal of this study was to investigate the possible differential drop in different types of cognitive tasks. Applied tests tapped fluid and crystallized intelligence, memory, and metacognition.
A sample of 116 participants participated in the study. Half of the participants were diagnosed with Parkinson's disease (average duration of disease 6.5 years) and control group participants equaled them in age, sex, and education level. All participants were tested using Raven's Colored Progressive Matrices (CPM), Crichton Vocabulary Scale (CVS), memory subtests from Wechsler Adult Intelligence Scale (WAIS DS-F, WAIS DS-B), and Mini-mental Status Examination (MMSE). Participants, and in the case of clinical group their caregivers as well, were asked questions concerning their metamemory and metacognition.
Parkinson's disease patients scored lower than control group on all instruments used but the difference was significant only on CPM (F[1,114]=19.14, p=0.001) and MMSE (F[1,110]=4.04, p=0.047).
Patients with Parkisons' disease have greater cognitive damage in fluid intelligence than in crystallized intelligence. They seem to have relatively accurate metamemory and metacognition.</description><identifier>ISSN: 0353-9504</identifier><identifier>PMID: 15311418</identifier><language>eng</language><publisher>Croatia</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Cognition - physiology ; Female ; Humans ; Intelligence - physiology ; Male ; Memory - physiology ; Middle Aged ; Parkinson Disease - physiopathology ; Parkinson Disease - psychology</subject><ispartof>Croatian medical journal, 2004-08, Vol.45 (4), p.451-456</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15311418$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Basić, Jasna</creatorcontrib><creatorcontrib>Katić, Silvija</creatorcontrib><creatorcontrib>Vranicć, Andrea</creatorcontrib><creatorcontrib>Zarevski, Predrag</creatorcontrib><creatorcontrib>Babić, Tomislav</creatorcontrib><creatorcontrib>Mahović-Lakusić, Darija</creatorcontrib><title>Cognition in Parkinson's disease</title><title>Croatian medical journal</title><addtitle>Croat Med J</addtitle><description>Studies of accentuated drop in cognitive functioning of Parkinson's disease patients mostly use global intelligence measures that have a masking effect on differential drop in specific cognitive abilities. The goal of this study was to investigate the possible differential drop in different types of cognitive tasks. Applied tests tapped fluid and crystallized intelligence, memory, and metacognition.
A sample of 116 participants participated in the study. Half of the participants were diagnosed with Parkinson's disease (average duration of disease 6.5 years) and control group participants equaled them in age, sex, and education level. All participants were tested using Raven's Colored Progressive Matrices (CPM), Crichton Vocabulary Scale (CVS), memory subtests from Wechsler Adult Intelligence Scale (WAIS DS-F, WAIS DS-B), and Mini-mental Status Examination (MMSE). Participants, and in the case of clinical group their caregivers as well, were asked questions concerning their metamemory and metacognition.
Parkinson's disease patients scored lower than control group on all instruments used but the difference was significant only on CPM (F[1,114]=19.14, p=0.001) and MMSE (F[1,110]=4.04, p=0.047).
Patients with Parkisons' disease have greater cognitive damage in fluid intelligence than in crystallized intelligence. They seem to have relatively accurate metamemory and metacognition.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Case-Control Studies</subject><subject>Cognition - physiology</subject><subject>Female</subject><subject>Humans</subject><subject>Intelligence - physiology</subject><subject>Male</subject><subject>Memory - physiology</subject><subject>Middle Aged</subject><subject>Parkinson Disease - physiopathology</subject><subject>Parkinson Disease - psychology</subject><issn>0353-9504</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j7tOxDAQRV2A2GXhF1AqqCKN7fGrRBEvaSUooI6cxEGGxA6ZpODvWYnd6jRHR_eesS1IJUunADfskugLQACivmAbriTnyO2WFVX-THGJORUxFW9-_o6JcrqjoosUPIUrdt77gcL1kTv28fjwXj2X-9enl-p-X04CzFL6zgTApgcTbKu9M86KBrxDjaoVHjsEYzoN1vWgpRJNr5zmQmF7mKG4kzt2-9-d5vyzBlrqMVIbhsGnkFeqtTZWG2MP4s1RXJsxdPU0x9HPv_Xpk_wDphNEUw</recordid><startdate>200408</startdate><enddate>200408</enddate><creator>Basić, Jasna</creator><creator>Katić, Silvija</creator><creator>Vranicć, Andrea</creator><creator>Zarevski, Predrag</creator><creator>Babić, Tomislav</creator><creator>Mahović-Lakusić, Darija</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200408</creationdate><title>Cognition in Parkinson's disease</title><author>Basić, Jasna ; Katić, Silvija ; Vranicć, Andrea ; Zarevski, Predrag ; Babić, Tomislav ; Mahović-Lakusić, Darija</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p207t-ad7e04bf07e8c6a97982b0a94645c2a4d4077d6089f06352bf5961254c4185193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Case-Control Studies</topic><topic>Cognition - physiology</topic><topic>Female</topic><topic>Humans</topic><topic>Intelligence - physiology</topic><topic>Male</topic><topic>Memory - physiology</topic><topic>Middle Aged</topic><topic>Parkinson Disease - physiopathology</topic><topic>Parkinson Disease - psychology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Basić, Jasna</creatorcontrib><creatorcontrib>Katić, Silvija</creatorcontrib><creatorcontrib>Vranicć, Andrea</creatorcontrib><creatorcontrib>Zarevski, Predrag</creatorcontrib><creatorcontrib>Babić, Tomislav</creatorcontrib><creatorcontrib>Mahović-Lakusić, Darija</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Croatian medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Basić, Jasna</au><au>Katić, Silvija</au><au>Vranicć, Andrea</au><au>Zarevski, Predrag</au><au>Babić, Tomislav</au><au>Mahović-Lakusić, Darija</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cognition in Parkinson's disease</atitle><jtitle>Croatian medical journal</jtitle><addtitle>Croat Med J</addtitle><date>2004-08</date><risdate>2004</risdate><volume>45</volume><issue>4</issue><spage>451</spage><epage>456</epage><pages>451-456</pages><issn>0353-9504</issn><abstract>Studies of accentuated drop in cognitive functioning of Parkinson's disease patients mostly use global intelligence measures that have a masking effect on differential drop in specific cognitive abilities. The goal of this study was to investigate the possible differential drop in different types of cognitive tasks. Applied tests tapped fluid and crystallized intelligence, memory, and metacognition.
A sample of 116 participants participated in the study. Half of the participants were diagnosed with Parkinson's disease (average duration of disease 6.5 years) and control group participants equaled them in age, sex, and education level. All participants were tested using Raven's Colored Progressive Matrices (CPM), Crichton Vocabulary Scale (CVS), memory subtests from Wechsler Adult Intelligence Scale (WAIS DS-F, WAIS DS-B), and Mini-mental Status Examination (MMSE). Participants, and in the case of clinical group their caregivers as well, were asked questions concerning their metamemory and metacognition.
Parkinson's disease patients scored lower than control group on all instruments used but the difference was significant only on CPM (F[1,114]=19.14, p=0.001) and MMSE (F[1,110]=4.04, p=0.047).
Patients with Parkisons' disease have greater cognitive damage in fluid intelligence than in crystallized intelligence. They seem to have relatively accurate metamemory and metacognition.</abstract><cop>Croatia</cop><pmid>15311418</pmid><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0353-9504 |
| ispartof | Croatian medical journal, 2004-08, Vol.45 (4), p.451-456 |
| issn | 0353-9504 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_66786778 |
| source | MEDLINE; Directory of Open Access Journals; EZB Electronic Journals Library |
| subjects | Adult Aged Aged, 80 and over Case-Control Studies Cognition - physiology Female Humans Intelligence - physiology Male Memory - physiology Middle Aged Parkinson Disease - physiopathology Parkinson Disease - psychology |
| title | Cognition in Parkinson's disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-13T17%3A27%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cognition%20in%20Parkinson's%20disease&rft.jtitle=Croatian%20medical%20journal&rft.au=Basi%C4%87,%20Jasna&rft.date=2004-08&rft.volume=45&rft.issue=4&rft.spage=451&rft.epage=456&rft.pages=451-456&rft.issn=0353-9504&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E66786778%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66786778&rft_id=info:pmid/15311418&rfr_iscdi=true |